Apellis Pharmaceuticals, Inc design mark 7114061
"Design mark 7114061" is a figurative mark owned by Apellis Pharmaceuticals, Inc., filed at the USPTO on June 15, 2022. It is registered and covers class 5 (Pharmaceuticals).
- Status
- Registered
- Since July 18, 2023
- Filed
- June 15, 2022
- Registered
- July 18, 2023
- Expires
- Not recorded
- Application no.
- 97460833
- Registration no.
- 7114061
- Office
- USPTO
- United States Patent and Trademark Office
- Mark type
- Figurative mark
- 1 class
Who owns Apellis Pharmaceuticals, Inc design mark 7114061
The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.
Owner
Apellis Pharmaceuticals, Inc.
Waltham, United States
Representative
John V. Hobgood, Esquire
Wilmer Cutler Pickering Hale and Dorr LLP
What the mark covers
The products and services Apellis Pharmaceuticals, Inc design mark 7114061 is filed for, grouped by Nice class.
Pharmaceutical preparations for the treatment of complement-mediated diseases and disorders
What has happened so far
Steps recorded by the USPTO, newest first.
- Assignment of ownership not updated automatically
- Notice of registration confirmation emailed
- Registered-principal register
- Official gazette publication confirmation e-mailed
- Published for opposition
- Notification of notice of publication e-mailed
- Approved for pub - principal register
- Notice of acceptance of amendment to allege use e-mailed
- Use amendment accepted
- Assigned to examiner
9 earlier steps on the official record.
About Apellis Pharmaceuticals, Inc design mark 7114061
Who owns the trademark "Design mark 7114061"?
The USPTO trademark "Design mark 7114061" (application 97460833) is owned by Apellis Pharmaceuticals, Inc.
What is the status of "Design mark 7114061"?
Its status at the USPTO is: registered.
When was "Design mark 7114061" registered?
It was registered on July 18, 2023.
Get this data via the API
Everything on this page comes from the Signa API. Pull Apellis Pharmaceuticals, Inc design mark 7114061 and marks like it into your own product with one request.
GET/v1/trademarks/{id}The full record: owners, classes, dates and images
GET/v1/trademarks/{id}/eventsEvery step in the office history
GET/v1/proceedings?trademark_id={id}Oppositions and cancellations against the mark
ID=tm_019d2aab-54d8-73ad-b807-c809e4d5e80b
curl https://api.signa.so/v1/trademarks/$ID \
-H "Authorization: Bearer $SIGNA_API_KEY"{
"id": "tm_019d2aab-54d8-73ad-b807-c809e4d5e80b",
"object": "trademark",
"mark_text": "[Design Mark]",
"status": {
"primary": "active",
"stage": "registered"
},
"office_code": "US",
"application_number": "97460833",
"filing_date": "2022-06-15",
"nice_classes": [
5
],
"owners": [
{
"name": "Apellis Pharmaceuticals, Inc.",
"entity_id": "ent_019f285f-a69d-752e-a5c3-8dfdb6e94d68"
}
]
}